Detalles de la búsqueda
1.
Combined immunosuppressants and less steroids in active graves' orbitopathy?
Clin Endocrinol (Oxf)
; 90(4): 525-527, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30549306
2.
Gut Microbiome in BALB/c and C57BL/6J Mice Undergoing Experimental Thyroid Autoimmunity Associate with Differences in Immunological Responses and Thyroid Function.
Horm Metab Res
; 50(12): 932-941, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30107619
3.
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
Br J Ophthalmol
; 108(2): 294-300, 2024 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36627174
4.
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy.
Ophthalmology
; 120(5): 1092-8, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23399378
5.
Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study.
J Clin Endocrinol Metab
; 108(8): 2065-2077, 2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36683389
6.
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy.
Thyroid
; 31(5): 821-828, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234032
7.
Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
Thyroid
; 31(2): 280-287, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940167
8.
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy.
Front Endocrinol (Lausanne)
; 12: 790246, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35145479
9.
Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
Microbiome
; 9(1): 45, 2021 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593429
10.
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience.
Front Endocrinol (Lausanne)
; 11: 432, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32733382
11.
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates.
Clin Immunol
; 131(2): 360-5, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19195932
12.
B cells in Graves' Orbitopathy: more than just a source of antibodies?
Eye (Lond)
; 33(2): 230-234, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30514895
13.
Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
Thyroid
; 29(12): 1828-1833, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860407
14.
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy.
Sci Rep
; 8(1): 8386, 2018 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29849043
15.
Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
Microbiome
; 6(1): 97, 2018 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29801507
16.
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
Lancet Diabetes Endocrinol
; 6(4): 287-298, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396246
17.
Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.
Eur J Endocrinol
; 178(6): 635-643, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650691
18.
Reference range of serum calcitonin in pediatric population.
J Clin Endocrinol Metab
; 100(5): 1780-4, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25955324
19.
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.
J Clin Endocrinol Metab
; 100(2): 422-31, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25494967
20.
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.
J Clin Endocrinol Metab
; 100(5): 1731-7, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25751109